MedTrace Logo

Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis

NCT04670653 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2022-08-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Magnólia nasal gel in the treatment of moderate-severe persistent or moderate-severe intermittent allergic rhinitis.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

MAGNÓLIA NASAL GEL

Magnólia nasal gel spray

DRUG

MOMETASONE FUROATE

Mometasone furoate nasal spray

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-07-31
Completion
2023-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04670653 on ClinicalTrials.gov